Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018144383) VACCINE AGAINST MORAXELLA CATARRHALIS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/144383 International Application No.: PCT/US2018/015721
Publication Date: 09.08.2018 International Filing Date: 29.01.2018
IPC:
A61K 38/16 (2006.01) ,A61K 39/02 (2006.01) ,C07K 14/21 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
02
Bacterial antigens
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
195
from bacteria
21
from Pseudomonadaceae (F)
Applicants:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK [US/US]; Technology Transfer, University At Buffalo Ub Commons, 520 Lee Entrance, Suite 109 Buffalo, NY 14228-2567, US
Inventors:
MURPHY, Timothy, F.; US
BRAUER, Aimee; US
Agent:
WATT, Rachel, S.; US
LOPINSKI, John, D.; US
CUTAIA, Alfonzo, I.; US
ROMAN, JR., Paul, J.; US
KADLE, Ranjana; US
Priority Data:
62/452,40831.01.2017US
Title (EN) VACCINE AGAINST MORAXELLA CATARRHALIS
(FR) VACCIN CONTRE MORAXELLA CATARRHALIS
Abstract:
(EN) Immunogenic compositions comprising Moraxella catarrhalis protein AfeA, its variants and/or fragments are provided. Also provided are methods for use of these compositions for preventing or treating otitis media and exacerbations of chronic obstructive pulmonary disease (COPD).
(FR) L'invention concerne des compositions immunogènes comprenant la protéine AfeA de Moraxella catarrhalis, ses variants et/ou fragments. L'invention concerne également des procédés d'utilisation de ces compositions pour prévenir ou traiter l'otite moyenne et les exacerbations de la bronchopneumopathie chronique obstructive (BPCO).
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)